Adrenocortical carcinoma · NCT03050268
SJFAMILY: Familial Investigations of Childhood Cancer Predisposition
- Status
- RECRUITING (ClinicalTrials.gov)
- Phase
- observational
- Sponsor
- St. Jude Children's Research Hospital
- Registry records
- CTGOV NCT03050268 (RECRUITING)Registry last updated 2026-06-17
Eligibility, line by line
| Verdict | In plain words (machine summary) | Registry text, verbatim | If unmet |
|---|---|---|---|
| inclusion inclusion · condition · confidence 0.90 | An individual who meets this protocol's definition of "Familial Cancer," as above. | "An individual who meets this protocol's definition of "Familial Cancer," as above." | |
| inclusion inclusion · condition · confidence 0.30 | Biologic relatives of an individual meeting this protocol's definition of "Familial Cancer," who are either affected or unaffected by cancer. | "Biologic relatives of an individual meeting this protocol's definition of "Familial Cancer," who are either affected or unaffected by cancer." | |
| inclusion inclusion · condition · confidence 0.30 | An individual with a history of cancer diagnosed under 26 years of age who has at least one first, second or third degree relative with a history of cancer diagnosed under 51 years of age | "An individual with a history of cancer diagnosed under 26 years of age who has at least one first, second or third degree relative with a history of cancer diagnosed under 51 years of age" | |
| inclusion inclusion · condition · confidence 0.30 | An individual who has been diagnosed with more than one cancer, at least one of which was diagnosed under 26 years of age | "An individual who has been diagnosed with more than one cancer, at least one of which was diagnosed under 26 years of age" | |
| inclusion inclusion · condition · confidence 0.85 | An individual with a clinical or molecular diagnosis of a known cancer predisposition syndrome | "An individual with a clinical or molecular diagnosis of a known cancer predisposition syndrome" | |
| inclusion inclusion · condition · confidence 0.85 | An individual with a congenital cancer diagnosed before 6 months of age | "An individual with a congenital cancer diagnosed before 6 months of age" | |
| inclusion inclusion · condition · confidence 0.85 | An individual with a rare pediatric cancer or tumor diagnosed before 26 years of age | "An individual with a rare pediatric cancer or tumor diagnosed before 26 years of age" | |
| exclusion exclusion · condition · confidence 0.80 | Excluding human papilloma virus-associated cervical cancer and non-melanoma skin cancer occurring in adults. | "Excluding human papilloma virus-associated cervical cancer and non-melanoma skin cancer occurring in adults." | |
| exclusion exclusion · consent · confidence 0.30 | An inability or unwillingness of the research participant or his/her legally authorized representative (LAR) to provide written informed consent. | "An inability or unwillingness of the research participant or his/her legally authorized representative (LAR) to provide written informed consent." | |
| exclusion exclusion · prior therapy · confidence 0.85 | The participant has received allogeneic bone marrow transplantation and has NO pre-transplant germline (cancer-unaffected) DNA available AND is unwilling to provide a skin sample. | "The participant has received allogeneic bone marrow transplantation and has NO pre-transplant germline (cancer-unaffected) DNA available AND is unwilling to provide a skin sample." |
Criteria extracted by claude-sonnet-5-5; 0 extracted quotes rejected for not matching the registry text.
Full eligibility text as the registry publishes it
NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many years from the time they enroll. If you are interested in clinical testing please consider seeing a local genetic counselor or other genetics professional. If you have already had clinical genetic testing and meet eligibility criteria for this study as shown below, you may enroll regardless of the results of your clinical genetic testing. DEFINITION OF FAMILIAR CANCER FOR THIS PROTOCOL: In this protocol, the definition of "Familial Cancer" is met if any of the following is present: * An individual with a history of cancer diagnosed under 26 years of age who has at least one first, second or third degree relative with a history of cancer diagnosed under 51 years of age; OR * An individual who has been diagnosed with more than one cancer, at least one of which was diagnosed under 26 years of age; OR * An individual with a clinical or molecular diagnosis of a known cancer predisposition syndrome; OR * An individual with a congenital cancer diagnosed before 6 months of age; OR * An individual with a rare pediatric cancer or tumor diagnosed before 26 years of age º Excluding human papilloma virus-associated cervical cancer and non-melanoma skin cancer occurring in adults. INCLUSION CRITERIA: * An individual who meets this protocol's definition of "Familial Cancer," as above. * Biologic relatives of an individual meeting this protocol's definition of "Familial Cancer," who are either affected or unaffected by cancer. EXCLUSION CRITERIA: * An inability or unwillingness of the research participant or his/her legally authorized representative (LAR) to provide written informed consent. * The participant has received allogeneic bone marrow transplantation and has NO pre-transplant germline (cancer-unaffected) DNA available AND is unwilling to provide a skin sample.
Routes in: how this trial is reached and paid for
US trials at ordinary hospitals: routine care is billed
In the US a sponsor funds the study drug and study-specific scans, but the routine care around them is billed to insurance. Without US cover that bill falls on you.
Cost is documented as the barrier that stops roughly 45 percent of US patients joining trials, before any question of being a non-resident. Eligibility on paper does not make a US site reachable. One email to the study coordinator asking what a non-resident without US insurance would be billed settles it either way.
Verify with: The study coordinator listed on the registry record
Ask first; potentially very high
Free patient navigation
myTomorrows (Amsterdam) provides medically trained, multilingual patient navigators who search ClinicalTrials.gov, EU CTIS and ISRCTN and can support a doctor through an expanded-access application. Free to patients and families.
A navigator keeps searching after any single page stops being current. Use it alongside this site, not instead of your oncologist.
Verify with: myTomorrows for patients
0
Sites (1)
United States
- St. Jude Children's Research Hospital, Memphis